Photo credit: Fred Hutch file
SEATTLE – March 31, 2014 – Anne McTiernan, M.D., Ph.D., a Fred Hutchinson Cancer Research Center breast and colorectal cancer prevention researcher, is among 10 people recently appointed to the Patient-Centered Outcomes Research Institute’s inaugural Advisory Panel on Clinical Trials.
McTiernan, a member of the Fred Hutch Public Health Sciences Division, is an internist and epidemiologist whose research focuses on identifying ways to prevent new or recurrent breast and colorectal cancer with a particular focus on physical activity, weight control and chemoprevention.
Members of the Advisory Panel on Clinical Trials will provide expertise on the design and implementation of randomized, controlled trials. Topics warranting their input include selection of appropriate patient-centered outcomes, informed consent of study participants, periodic evaluations of PCORI’s clinical trial portfolio, and the readiness of trial results for dissemination.
The panelists and four alternates, comprising biostatisticians, epidemiologists, patients, patient advocates and bioethics, were selected from 231 applicants. The panel will convene for its first meeting May 1 in Washington, D.C.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.